National Institute for Occupational Safety and Health Advisory Board on Radiation and Worker Health, 20755-20756 [05-8088]

Download as PDF Federal Register / Vol. 70, No. 76 / Thursday, April 21, 2005 / Notices Highlights; overview of USCS Report; update of the National Report; update of expert panel meetings; Performance based budgeting; providing Mammography Screening for younger Women; getting the facts on Tribal & Territories NBCCEDP Program; using data to drive program planning; serving American Indian Populations; Coalition; Partnership & Collaboration; Survivorship; Case Management Evaluation. Agenda items are subject to change as priorities dictate. For More Information Contact: Debra Younginer, Executive Secretary, BCCEDCAC, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop K–57, Chamblee, Georgia 30316, Telephone: 770–488–1074. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 15, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–7992 Filed 4–20–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers For Disease Control and Prevention (CDC) announce the following meeting: Name: National Center for Injury Prevention and Control (NCIPC), Initial Review Group (IRG). Time and Date: 1 p.m.–5 p.m., May 20, 2005. Place: The conference call will originate at the National Center for Injury Prevention and Control, in Atlanta, Georgia. Status: Closed: 1 p.m.–5 p.m., May 20, 2005. Purpose: This group is charged with providing advice and guidance to the Secretary of Health and Human Services and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control and supports Injury Control Research Centers (ICRCs). VerDate jul<14>2003 14:55 Apr 20, 2005 Jkt 205001 Matters to be Discussed: Agenda items include an overview of the injury program, discussion of the review process and panelists’ responsibilities, and the review of and vote on applications. From 1 p.m. to 5 p.m., May 20, the Group will review individual research cooperative agreement in response to announcements: #05098, Research in Areas of Acute Care, Disability, and Rehabilitation at the Notre Dame Center for Orthopedic Research and Engineering; #05099, University of Oklahoma Health Sciences Center, Developmental Injury Prevention Research Center; #05100, National Foundation for Trauma Care: The Study of the Impact of a Terrorist Attack on Individual Trauma Centers; #05101, Pennsylvania Chapter of the American College of Emergency Physicians; #05106, Iowa State University, Center for the Study of Violence. This meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, NE., M/S K02, Atlanta, Georgia 30341–3724, telephone (770) 488– 4655. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities for both CDC and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 15, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–7995 Filed 4–20–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Injury Prevention and Control Initial Review Group In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following meeting: Name: National Center for Injury Prevention and Control (NCIPC), Initial Review Group (IRG). Times and Dates: 12:30 p.m.–5:30 p.m., May 18, 2005. 12:30 p.m.–5:30 p.m., May 19, 2005. Place: The conference call will originate at the National Center for Injury Prevention and Control, in Atlanta, Georgia. PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 20755 Status: Closed: 12:30 p.m.–5:30 p.m., May 18, 2005. Closed: 12:30 p.m.–5:30 p.m., May 19, 2005. Purpose: This group is charged with providing advice and guidance to the Secretary of Health and Human Services and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control and supports Injury Control Research Centers (ICRCs). Matters to be Discussed: Agenda items include an overview of the injury program, discussion of the review process and panelists’ responsibilities, and the review of and vote on applications. Beginning at 12:30 p.m., May 18, through 5:30 p.m., May 19, the Group will review individual research cooperative agreement in response to announcement: #05020, Youth Violence through Community-Level Change. This meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Agenda items are subject to change as priorities dictate. For Further Information Contact: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, NE., M/S K02, Atlanta, Georgia 30341–3724, telephone 770–488– 4655. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 15, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–7989 Filed 4–20–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Advisory Board on Radiation and Worker Health In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting: E:\FR\FM\21APN1.SGM 21APN1 20756 Federal Register / Vol. 70, No. 76 / Thursday, April 21, 2005 / Notices Name: Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) and Subcommittee for Dose Reconstruction and Site Profile Reviews. Subcommittee Meeting Time and Date: 8 a.m.–11:30 a.m., April 25, 2005. Committee Meeting Times and Dates: 1 p.m.–6:15 p.m., April 25, 2005. 8 a.m.–5:15 p.m., April 26, 2005. 7 p.m.–8:30 p.m., April 26, 2005. 8 a.m.–5:30 p.m., April 27, 2005. Place: Crowne Plaza Five Seasons Hotel, 350 1st Avenue Northeast, Cedar Rapids, Iowa 52401, telephone (319) 363–8161, fax (319) 363–3804. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 200 people. Background: The ABRWH was established under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) of 2000 to advise the President, delegated to the Secretary of Health and Human Services (HHS), on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Board include providing advice on the development of probability of causation guidelines which have been promulgated by HHS as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, and renewed on August 3, 2003. Purpose: This board is charged with (a) Providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS on the scientific validity and quality of dose reconstruction efforts performed for this Program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to be Discussed: Agenda for this meeting will focus on Review of the Draft Minutes; Iowa Army Ammunition Plant Technical Basis Document and Special Exposure Cohort (SEC) Petition; Mallinckrodt (Destrehan Street Facility) Technical Basis Document and SEC Petition; Program updates by NIOSH and DOL; Future Schedule; Policy Concerning Data Integrity; Board Operating Procedures; Discussion of first 20 Dose Reconstruction Reviews; SEC Task for SC&A, Inc.; and SC&A, Inc. Contract Update Status. There will be an evening VerDate jul<14>2003 14:55 Apr 20, 2005 Jkt 205001 public comment period scheduled for April 26, 2005 and general public comment periods during the day on April 25th and 27th. The Subcommittee will convene on April 25, 2005, from 8 a.m.–11:30 a.m. and will focus on review of draft minutes; Report on the Review of the First 20 Dose Reconstructions; the process to accomplish review of SC&A Task III Report; Status Report of On-Going Activities and Future Schedule; as well as Comments by Members of Congress. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. Contact Person for More Information: Dr. Lewis V. Wade, Executive Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, Ohio 45226, telephone (513) 533–6825, fax (513) 533–6826. This notice is being published less than 15 days prior to the meeting due to the unexpected urgency of the topics that will be discussed. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 18, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–8088 Filed 4–19–05; 12:27 pm] BILLING CODE 4163–19–P U.S.C. 280f, as added by Public Law 105– 392) to establish a National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) research, programs and surveillance; and (2) to otherwise meet the general needs of populations actually or potentially impacted by FAS and FAE. Matters to be Discussed: Agenda items include: Prevention and Post-Exposure working group sessions; updates on progress of Task Force working groups; discussion of future activities to promote the Surgeon General’s Advisory; updates from the Interagency Coordinating Committee on Fetal Alcohol Syndrome, the CDC and other Federal agencies, and liaison members; future meeting topics; and scheduling of the next meeting. Agenda items are subject to change as priorities dictate. For Further Information Contact: Mary Kate Weber, M.P.H., Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E–86), Atlanta, Georgia 30333, telephone 404/498–3926, fax 404/ 498–3550. The Director, Management and Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 14, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–7991 Filed 4–20–05; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect: Meeting Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Federal advisory committee meeting. Name: National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE). Times and Dates: 8:30 a.m.–4:30 p.m., June 15, 2005. 8:30 a.m.–12 noon, June 16, 2005. Place: Doubletree Hotel Atlanta/Buckhead, 3342 Peachtree Road, NE., 30326, telephone 404/231–1234, fax 404/231–3112. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 65 people. Purpose: The Secretary is authorized by the Public Health Service Act, Section 399G, (42 Agency for Toxic Substances and Disease Registry Public Meeting of the Citizens Advisory Committee on Public Health Service Activities and Research at Department of Energy (DOE) Sites: Oak Ridge Reservation Health Effects Subcommittee Name: Public meeting of the Citizens Advisory Committee on PHS Activities and Research at DOE Sites: Oak Ridge Reservation Health Effects Subcommittee (ORRHES). Time and Date: 12 p.m.–2 p.m., May 3, 2005. Place: ATSDR/Oak Ridge Field Office, 197 South Tulane, Oak Ridge, TN. Telephone: (865) 220–0295. Participants may participate via phone. PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 E:\FR\FM\21APN1.SGM 21APN1

Agencies

[Federal Register Volume 70, Number 76 (Thursday, April 21, 2005)]
[Notices]
[Pages 20755-20756]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-8088]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Institute for Occupational Safety and Health Advisory 
Board on Radiation and Worker Health

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:


[[Page 20756]]


    Name: Advisory Board on Radiation and Worker Health (ABRWH), 
National Institute for Occupational Safety and Health (NIOSH) and 
Subcommittee for Dose Reconstruction and Site Profile Reviews.

Subcommittee Meeting Time and Date:
    8 a.m.-11:30 a.m., April 25, 2005.
Committee Meeting Times and Dates:
    1 p.m.-6:15 p.m., April 25, 2005.
    8 a.m.-5:15 p.m., April 26, 2005.
    7 p.m.-8:30 p.m., April 26, 2005.
    8 a.m.-5:30 p.m., April 27, 2005.
    Place: Crowne Plaza Five Seasons Hotel, 350 1st Avenue 
Northeast, Cedar Rapids, Iowa 52401, telephone (319) 363-8161, fax 
(319) 363-3804.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 200 people.
    Background: The ABRWH was established under the Energy Employees 
Occupational Illness Compensation Program Act (EEOICPA) of 2000 to 
advise the President, delegated to the Secretary of Health and Human 
Services (HHS), on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Board include providing advice on the 
development of probability of causation guidelines which have been 
promulgated by HHS as a final rule, advice on methods of dose 
reconstruction which have also been promulgated by HHS as a final 
rule, advice on the scientific validity and quality of dose 
estimation and reconstruction efforts being performed for purposes 
of the compensation program, and advice on petitions to add classes 
of workers to the Special Exposure Cohort (SEC). In December 2000, 
the President delegated responsibility for funding, staffing, and 
operating the Board to HHS, which subsequently delegated this 
authority to the CDC. NIOSH implements this responsibility for CDC. 
The charter was issued on August 3, 2001, and renewed on August 3, 
2003.
    Purpose: This board is charged with (a) Providing advice to the 
Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS on the 
scientific validity and quality of dose reconstruction efforts 
performed for this Program; and (c) upon request by the Secretary, 
HHS, advise the Secretary on whether there is a class of employees 
at any Department of Energy facility who were exposed to radiation 
but for whom it is not feasible to estimate their radiation dose, 
and on whether there is reasonable likelihood that such radiation 
doses may have endangered the health of members of this class.
    Matters to be Discussed: Agenda for this meeting will focus on 
Review of the Draft Minutes; Iowa Army Ammunition Plant Technical 
Basis Document and Special Exposure Cohort (SEC) Petition; 
Mallinckrodt (Destrehan Street Facility) Technical Basis Document 
and SEC Petition; Program updates by NIOSH and DOL; Future Schedule; 
Policy Concerning Data Integrity; Board Operating Procedures; 
Discussion of first 20 Dose Reconstruction Reviews; SEC Task for 
SC&A, Inc.; and SC&A, Inc. Contract Update Status. There will be an 
evening public comment period scheduled for April 26, 2005 and 
general public comment periods during the day on April 25th and 
27th.
    The Subcommittee will convene on April 25, 2005, from 8 a.m.-
11:30 a.m. and will focus on review of draft minutes; Report on the 
Review of the First 20 Dose Reconstructions; the process to 
accomplish review of SC&A Task III Report; Status Report of On-Going 
Activities and Future Schedule; as well as Comments by Members of 
Congress.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may 
be submitted. Any written comments received will be provided at the 
meeting and should be submitted to the contact person below well in 
advance of the meeting.
    Contact Person for More Information: Dr. Lewis V. Wade, 
Executive Secretary, NIOSH, CDC, 4676 Columbia Parkway, Cincinnati, 
Ohio 45226, telephone (513) 533-6825, fax (513) 533-6826.
    This notice is being published less than 15 days prior to the 
meeting due to the unexpected urgency of the topics that will be 
discussed.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.


    Dated: April 18, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-8088 Filed 4-19-05; 12:27 pm]
BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.